Patents by Inventor Eva Bresson

Eva Bresson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF
    Publication number: 20130324545
    Abstract: AKR1B1 (EC 1.1.1.21) is an aldose reductase that has mainly been associated with the polyol pathway, and more recently with lipid deperoxidation. We have discovered that the primary activity of this enzyme is rather a PGFS activity, catalyzing the transformation of PGH2 into PGF2?. AKR1B1 as a therapeutic target, and method for modulating its expression and activity are provided. Methods for regulating the expression and activity of PGF2? are also provided.
    Type: Application
    Filed: July 17, 2013
    Publication date: December 5, 2013
    Applicant: UNIVERSITE LAVAL
    Inventors: Michael Fortier, Pierre Chapdelaine, Eva Bresson, Éric Madore
  • METHODS FOR THE REGULATION OF THE PROSTAGLANDIN F SYNTHASE (PGFS) ACTIVITY OF AKR1B1 AND USES THEREOF
    Publication number: 20110236394
    Abstract: AKR1B1 (EC 1.1.1.21) is an aldose reductase that has mainly been associated with the polyol pathway, and more recently with lipid deperoxidation. We have discovered that the primary activity of this enzyme is rather a PGFS activity, catalyzing the transformation of PGH2 into PGF2?. AKR1B1 as a therapeutic target, and method for modulating its expression and activity are provided. Methods for regulating the expression and activity of PGF2? are also provided.
    Type: Application
    Filed: November 14, 2008
    Publication date: September 29, 2011
    Applicant: UNIVERSITE LAVAL
    Inventors: Michel Fortier, Pierre Chapdelaine, Eva Bresson, Eric Madore